102 results match your criteria: "universitaire Angers.[Affiliation]"
JAMA Netw Open
December 2024
Department of Internal Medicine, CEREMAIA, Sorbonne Université, Hôpital Tenon, Assistance Publique-Hôpitaux Paris, Paris, France.
J Mycol Med
December 2024
Laboratoire de Parasitologie-Mycologie, Hôpital Européen Georges Pompidou, Hôpital Universitaire Necker, Unité de Parasitologie-Mycologie, Service de Microbiologie, Paris, France. Electronic address:
This study investigates the diagnostic practices for mucormycosis among 30 French University Hospital mycology laboratories, in 2024. All laboratories perform both direct examination and culture, with fluorescent brighteners being the most commonly used method for direct examination. While 77 % of the participating laboratories routinely identify Mucorales to the species level, with 70 % having adopted Mucorales-specific quantitative PCR, primarily for the diagnosis of invasive fungal infections.
View Article and Find Full Text PDFClin Infect Dis
September 2024
Division of Critical Care Medicine, and Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, Canada.
JMIR Med Inform
September 2024
Inserm, UMR 1085 Ester, Centre Hospitalier Universitaire Angers, Angers, France.
Background: The optimization of patient care pathways is crucial for hospital managers in the context of a scarcity of medical resources. Assuming unlimited capacities, the pathway of a patient would only be governed by pure medical logic to meet at best the patient's needs. However, logistical limitations (eg, resources such as inpatient beds) are often associated with delayed treatments and may ultimately affect patient pathways.
View Article and Find Full Text PDFJ Exp Med
October 2024
Université Côte d'Azur, INSERM, C3M , Nice, France.
A growing number of patients presenting severe combined immunodeficiencies attributed to monoallelic RAC2 variants have been identified. The expression of the RHO GTPase RAC2 is restricted to the hematopoietic lineage. RAC2 variants have been described to cause immunodeficiencies associated with high frequency of infection, leukopenia, and autoinflammatory features.
View Article and Find Full Text PDFCrit Care
July 2024
Laboratoire de Psychologie: Dynamiques Relationnelles Et Processus Identitaires (Psy-DREPI), Université de Bourgogne Franche-Comté, EA7458, Dijon, France.
Background: Critical-illness survivors may experience post-traumatic stress disorder (PTSD) and quality-of-life impairments. Resilience may protect against psychological trauma but has not been adequately studied after critical illness. We assessed resilience and its associations with PTSD and quality of life, and also identified factors associated with greater resilience.
View Article and Find Full Text PDFRheumatology (Oxford)
June 2024
Service de Médecine Interne, Centre de référence des maladies auto-immunes et auto-inflammatoires systémiques rares d'Ile-de-France, de l'Est et de l'Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, France.
Objectives: Data about hydroxychloroquine (HCQ) levels during pregnancy are sparse. We assessed HCQ whole blood levels at first trimester of pregnancy as a potential predictor of maternal and obstetric/fetal outcomes in patients with systemic lupus erythematosus (SLE).
Methods: We included pregnant SLE patients enrolled in the prospective GR2 study receiving HCQ, with at least one available first-trimester whole-blood HCQ assay.
J Thromb Haemost
August 2024
Department of Haemostasis, Regional University Hospital Centre Tours, Tours, France; Institut National de la Santé et de la Recherche Médicale INSERM U1327 ISCHEMIA, Membrane Signalling and Inflammation in Reperfusion Injuries, Université de Tours, Tours, France.
Background: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a complication of adenoviral-based vaccine against SARS-CoV-2 due to prothrombotic immunoglobulin (Ig) G antibodies to platelet factor 4 (PF4) and may be difficult to distinguish from heparin-induced thrombocytopenia (HIT) in patients treated with heparin.
Objectives: We assessed the usefulness of competitive anti-PF4 enzyme immunoassays (EIAs) in this context.
Methods: The ability of F(ab')2 fragments of 1E12, 1C12, and 2E1, 3 monoclonal anti-PF4 antibodies, to inhibit the binding of human VITT or HIT antibodies to PF4 was evaluated using EIAs.
PLoS One
April 2024
Centre Hospitalier Universitaire Angers, BAT IBS-4 rue Larrey, Angers, France.
Introduction: Infection by hepatitis B virus (HBV) is a major issue in public health. The prevalence of HBV in Chad is 12.4%, all age groups considered.
View Article and Find Full Text PDFJ Infect Dis
October 2024
Centre for Infectious Disease Control, Dutch National Public Health Institute, Bilthoven, The Netherlands.
Blood
June 2024
Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Basel, Switzerland.
Transfus Clin Biol
August 2024
Etablissement français du sang, Hôpital Henri Mondor, 1 rue Gustave Eiffel, 94010 Créteil, France; INSERM U955 équipe 2, Institut Mondor de Recherche Biomédicale (IMRB), Créteil, France.
Clin Nucl Med
May 2024
From the Departments of Nuclear Medicine, Centre Hospitalier Universitaire Angers, Angers, France.
Gamma/delta T-cell lymphoma is a rare and aggressive subtype of primary cutaneous lymphoma. Clinical manifestations typically include the development of subcutaneous nodules and ulcerated plaques. Some forms present as panniculitis with hemophagocytic syndrome.
View Article and Find Full Text PDFJAMA Neurol
March 2024
Nantes Université, CHU Nantes, Inserm, CIC 14131413, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France.
Ann Dermatol Venereol
March 2024
Dermatology Department, Centre Hospitalier Henri Mondor, Villejuif, France.
Emergencias
December 2023
Servicio de Urgencias, Hôpital Pitié-Salpêtrière, Sorbonne Université, París, Francia. FHU IMPEC Improving Emergency Care, UMR 1166, IHU ICAN, Sorbonne Université, París, Francia.
Am J Kidney Dis
March 2024
Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1155, Soins Intensifs Néphrologiques et Rein Aigu, Département de Néphrologie, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France. Electronic address:
Blood
November 2023
Hematology Laboratory, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Cureus
June 2023
Vascular Surgery, French College of Vascular and Endovascular Surgery (CFCVE), Paris, FRA.
In France, since March 2020, the healthcare system has experienced a significant decrease or even suspension of surgical activity and admissions due to the coronavirus disease 2019 (COVID-19). This activity is essential to the acquisition of technical skills for all trainees enrolled in the Vascular and Endovascular Surgery Training Program either as residents or fellows. The crisis may have affected the training of vascular surgery trainees.
View Article and Find Full Text PDFJ Clin Microbiol
June 2023
Universitaire Angers, Nantes Université, CHU Angers, Inserm, INCIT, Angers, France.
Buruli ulcer (BU) is a neglected tropical disease caused by Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbidity. In November 2012, a field laboratory fully equipped for the rapid on-site quantitative PCR (qPCR) diagnosis of M.
View Article and Find Full Text PDFPLoS Negl Trop Dis
May 2023
University of Angers, Nantes Université, CHU Angers, Inserm, INCIT, Angers, France.
Context: Since 2013, the World Health Organization has recommended integrated control strategies for neglected tropical diseases (NTDs) with skin manifestations. We evaluated the implementation of an integrated approach to the early detection and rapid treatment of skin NTDs based on mobile clinics in the Ouémé and Plateau areas of Benin.
Methods: This descriptive cross-sectional study was performed in Ouémé and Plateau in Benin from 2018 to 2020.
Neurology
June 2023
From the Hôpital La Pitié-Salpêtrière (F.M., M-P.L., C.D.), Assistance-Publique Hôpitaux de Paris, Inserm U1127; Sorbonne University (D.Gras), Inserm U1127, CNRS UMR7225, Paris Brain Institute; U1141 Neurodiderot (D.Gras), équipe 5 InDev, Inserm, CEA, UP UNIACT, Neurospin, Joliot, DRF, CEA-Saclay; Metafora Biosystems (M.N., V.P.); Institut de Génétique Moléculaire de Montpellier (D.Giovannini), Univ. Montpellier, CNRS; Service de Neurologie Pédiatrique (M.A.), Hôpital Necker-Enfants Malades, Assistance-Publique Hôpitaux de Paris; Service de Génétique (M.B.), Centre Hospitalier Universitaire Angers; Service de Neuropédiatrie (A.D.S-M.), Hôpital de Hautepierre, Strasbourg; Sorbonne Université (D.D.), Service de Neuropédiatrie-Pathologie du développement, Hôpital Trousseau AP-HP.SU, FHU I2D2, Paris; Service de Neurologie et Réanimation Pédiatrique (N.E.), APHP, Hôpital Raymond Poincaré, Garches; Service de Neurologie Pédiatrique (A.G.), Hôpital Nord, Grenoble; Service de Neurologie Pédiatrique (C.H.L.C.), et Unité de recherche clinique, module plurithématique sous axe pédiatrique CI 1436, Hôpital des enfants, CHU Toulouse; Service de Neurologie Pédiatrique (C.H.), Hôpital La Timone, Assistance-Publique Hôpitaux de Marseille; Service de Neuropédiatrie (S.N.T.T.), CRMR Epilepsies Rares, Hôpital Roger Salengro, Lille; Service de Neuropédiatrie et handicaps (M.P.), Hôpital pédiatrique Gatien de Clocheville, CHU de Tours; Pole Mère Enfant (S.R.), Centre Hospitalier de la Côte Basque, Bayonne; Service de Neuropédiatrie (A.R.), Hôpital Mère-Enfant, Nantes; Département de Neuropédiatrie, Centre d'investigation Clinique Inserm (A.R.), INM, Univ Montpellier, INSERM U 1298, CHU Montpellier, CIC1411; Service de Pédiatrie (C.Sarret), Hôpital Estaing, CHU Clermont-Ferrand; Service de Neurologie Pédiatrique (C.Sevin), Hôpital Bicêtre, Assistance-Publique Hôpitaux de Paris; Service de Neurologie Pédiatrique (D.V.), Hôpital Femme Mère Enfant, Centre Hospitalier de Lyon; Institut de Génétique Moléculaire de Montpellier (M.S.), Univ. Montpellier, CNRS; Laboratoire Cerba (J-M.C.), Saint-Ouen l'Aumône, France; Department of Pediatrics (R.P.), Aghia Sofia Hospital, University of Athens, Greece; Department of Neurology (A.G-C.), Hospital Sant Joan de Déu, Barcelona, Spain; Service de Biochimie et Génétique (S.V.), Hôpital Bichat Claude Bernard, APHP, Paris; CRMR Leukofrance Service de neuropediatrie (O.B-T.), Hôpital Robert Debré, AP-HP, Paris; UMR1141, Neurodiderot Université de Paris, France; Department of Pediatrics (D.C.D.V.), Columbia University Irving Medical Center, New York.
Background And Objective: GLUT1 deficiency syndrome (Glut1DS) is a treatable neurometabolic disease that causes a wide range of neurologic symptoms in children and adults. However, its diagnosis relies on an invasive test, that is, a lumbar puncture (LP) to measure glycorrhachia, and sometimes complex molecular analyses of the gene. This procedure limits the number of patients able to receive the standard of care.
View Article and Find Full Text PDFClin Chem Lab Med
June 2023
University of Angers, Inserm 1083, CNRS 6015, Mitolab Team, MITOVASC Institute, SFR ICAT, Angers, France.
Objectives: VEXAS syndrome is a newly described autoinflammatory disease associated with somatic mutations and vacuolization of myeloid precursors. This disease possesses an increasingly broad spectrum, leading to an increase in the number of suspected cases. Its diagnosis via bone-marrow aspiration and -gene sequencing is time-consuming and expensive.
View Article and Find Full Text PDFBMC Infect Dis
November 2022
COREVIH Pays de la Loire, CHU Nantes Hôtel-Dieu, 1 Place Alexis Ricordeau, 44093, Nantes Cedex 1, France.
Background: In the general population, sport activity is associated with better health and better self-esteem. Among people living with HIV (PLHIV), sport activity could also be associated with better self-esteem. The main objective of our study was to assess the association between sport activity and self-esteem among people living with HIV.
View Article and Find Full Text PDFJ Exp Med
January 2023
Necker Enfants Malades Institute, INSERM U1151/CNRS UMR 8253, Action thématique incitative sur programme-Avenir Team Auto-Immune and Immune B cell, University Paris Cité, University Paris-Est-Créteil, Créteil, France.